Results 31 to 40 of about 87,645 (340)

BCG and the Niacin Drugs

American Journal of Public Health and the Nations Health, 1952

openalex   +4 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells1

Journal of Lipid Research, 2004
Niacin is a widely used lipid-regulating agent in dyslipidemic patients. Previously, we have shown that niacin inhibits triacylglycerol synthesis.
Shobha H. Ganji, S. Tavintharan, Daming Zhu, Yiding Xing, Vaijinath S. Kamanna, Moti L. Kashyap   +5 more
doaj   +1 more source

Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomized controlled trials [PDF]

, 2016
Objective Previous studies have suggested that niacin treatment raises glucose levels in patients with diabetes and may increase the risk of developing diabetes.
Goldie, Christina, McCoy, Cody, Nguyen, Peter, Preiss, David, Taylor, Allen J., Zhao, Xue-Qiao   +5 more
core   +1 more source

Effect of Niacin on Growth Performance, Intestinal Morphology, Mucosal Immunity and Microbiota Composition in Weaned Piglets

Animals, 2021
Simple Summary The protective effect of niacin on growth performance and gut health of weaned piglets and the underlying mechanism remains unclear despite it being a common additive in pig diets.
Shilong Liu, Xiaoping Zhu, Y. Qiu, Li Wang, X. Shang, K. Gao, Xuefen Yang, Zong-yong Jiang   +7 more
semanticscholar   +1 more source

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles. [PDF]

, 2017
Treatment of dyslipidemia patients with lipid-lowering drugs leads to a significant reduction in low-density lipoproteins (LDL) level and a low to moderate level of increase in high-density lipoprotein (HDL) cholesterol in plasma.
Alderete, Benjamin, Amento, Edward P, Kong, Raymond, Liu, David, Lundry, Jason, Madasamy, Shanmugavel, Robinson, J Paul, Wu, Alan HB   +7 more
core   +1 more source

EFFECT OF LOW-DOSE NIACIN ON DYSLIPIDEMIA, SERUM PHOSPHORUS LEVELS AND ADVERSE EFFECTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Kidney Research and Clinical Practice, 2012
Niacin supplementation improves dyslipidemia and lowers serum phosphorus levels in chronic kidney disease (CKD) patients. However, its adverse effects, including hot flusing, hinder the administration of niacin.
Won Suk An, Hyo Jin Kang, Ki Hyun Kim
doaj   +1 more source

Neonatal Pellagra. [PDF]

Clin Case Rep
ABSTRACT When infants develop an intractable rash, even in developed countries, considering the possibility of malnutrition and taking the mother's dietary history are important. The nutritional status of preterm infants after fortification of the mother's milk is discontinued should be carefully monitored.
Kitaoka H, Kakiuchi S.
europepmc   +2 more sources

Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system

Acta Neuropathologica, 2020
Remyelination following CNS demyelination restores rapid signal propagation and protects axons; however, its efficiency declines with increasing age. Both intrinsic changes in the oligodendrocyte progenitor cell population and extrinsic factors in the ...
Khalil S. Rawji, Adam M. H. Young, Tanay Ghosh, Nathan J. Michaels, R. Mirzaei, J. Kappen, Kathleen L. Kolehmainen, Nima Alaeiilkhchi, Brian M. Lozinski, M. Mishra, Annie Pu, Weiwen Tang, S. Zein, D. K. Kaushik, M.B. Keough, Jason R. Plemel, Fiona Calvert, Andrew J. Knights, Daniel J. Gaffney, W. Tetzlaff, R. Franklin, V. Yong   +21 more
semanticscholar   +1 more source

Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets

Briefings Bioinform., 2020
Objectives Patients with colorectal cancer (CRC) may be susceptible to the coronavirus disease-2019 (COVID-19). However, anti-CRC/COVID-19 treatment options are currently unavailable.
Rong-chun Li, Yu Li, X. Liang, Lu Yang, M. Su, K. Lai   +5 more
semanticscholar   +1 more source